During the past decade, New Hope Research Development conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "New Hope Research Development" are "Crohn Disease" (3 trials), "Gastroparesis" (3 trials), "Diabetes Mellitus" (2 trials), "Acute Pain" (1 trials) and "Defect of Articular Cartilage" (1 trials). Many other conditions were trialed in "New Hope Research Development" in a lesser frequency.

Most popular intervention types in "New Hope Research Development" are "Drug" (7 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "Relamorelin" (2 trials), "HB/APAP" (1 trials) and "Hyalofast" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Hope Research Development" are 8 trials for "All" genders.

Currently, there are NaN active trials in "New Hope Research Development". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in New Hope Research Development, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in New Hope Research Development, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".